KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clorox (CLX) Cash & Equivalents (2016 - 2026)

Clorox has reported Cash & Equivalents over the past 18 years, most recently at $1.2 billion for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 425.22% year-over-year to $1.2 billion; the TTM value through Mar 2026 reached $1.2 billion, up 425.22%, while the annual FY2025 figure was $167.0 million, 17.33% down from the prior year.
  • Cash & Equivalents for Q1 2026 was $1.2 billion at Clorox, up from $227.0 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $1.2 billion in Q1 2026 and troughed at $166.0 million in Q3 2025.
  • A 5-year average of $312.6 million and a median of $241.0 million in 2022 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: plummeted 51.02% in 2022 and later skyrocketed 425.22% in 2026.
  • Year by year, Cash & Equivalents stood at $168.0 million in 2022, then surged by 111.31% to $355.0 million in 2023, then dropped by 18.31% to $290.0 million in 2024, then decreased by 21.72% to $227.0 million in 2025, then soared by 422.91% to $1.2 billion in 2026.
  • Business Quant data shows Cash & Equivalents for CLX at $1.2 billion in Q1 2026, $227.0 million in Q4 2025, and $166.0 million in Q3 2025.